Proteomics in immunity and herpes simplex encephalitis

Expert Review of Proteomics

Volumn 11, Issue 1, 2014, Pages 21-29

  Pérez De Diego, Rebeca ^a   Mulvey, Claire ^b,c   Casanova, Jean Laurent ^d,e,f,g,h   Godovac Zimmermann, Jasminka ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d IMAGINE INSTITUTE   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f ROCKEFELLER UNIVERSITY   (United States)

^g KING SAUD UNIVERSITY   (Saudi Arabia)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

genomics; herpes simplex encephalitis; herpes simplex virus 1; infectious diseases; interferon; proteomics; SILAC; systems biology; TLR3

Indexed keywords

BIOINFORMATICS; CHILDHOOD DISEASE; DISEASE PREDISPOSITION; EXOME; GENETIC DISORDER; GENOMICS; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; HUMAN; IMMUNITY; PROTEOMICS; REVIEW; VIRUS INFECTION;

ANIMALS; COMPUTATIONAL BIOLOGY; ENCEPHALITIS, HERPES SIMPLEX; EXOME; HUMANS; IMMUNITY; PROTEOMICS;

EID: 84893049164     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.2014.864954     Document Type: Review

References (39)

1. Casanova JL, Abel L. Human genetics of infectious diseases: a unified theory. EMBO J. 26(4), 915-922 (2007).
2. Casanova JL, Abel L. The genetic theory of infectious diseases: a brief history and selected illustrations. Annu. Rev. Genomics Hum. Genet. 14, 215-243 (2013).
3. Alcais A, Abel L, Casanova JL. Human genetics of infectious diseases: between proof of principle and paradigm. J. Clin. Invest. 119(9), 2506-2514 (2009).
4. Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science 317(5838), 617-619 (2007).
5. Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral. Res. 71(2-3), 141-148 (2006).
6. De Tiege X, Rozenberg F, Heron B. The spectrum of herpes simplex encephalitis in children. Eur. J. Paediatr. Neurol. 12(2), 72-81 (2008).
7. Abel L, Plancoulaine S, Jouanguy E et al. Age-dependent mendelian predisposition to herpes simplex virus type 1 encephalitis in childhood. J. Pediatr. 157(4), 623-629 (2010).
8. Bustamante J, Picard C, Fieschi C et al. A novel X-linked recessive form of Mendelian susceptibility to mycobaterial disease. J. Med. Genet. 44(2), e65 (2007).
9. Whitley RJ, Alford CA, Hirsch MS et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N. Engl. J. Med. 314(3), 144-149 (1986).
10. Whitley RJ, Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin. Infect. Dis. 20(2), 414-420 (1995).
11. Kneen R, Michael BD, Menson E et al. Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J. Infect. 64(5), 449-477 (2012).
12. Ng SB, Turner EH, Robertson PD et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461(7261), 272-276 (2009).
13. Choi M, Scholl UI, Ji W et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc. Natl Acad. Sci. USA 106(45), 19096-19101 (2009).
14. Byun M, Ma CS, Akcay A et al. Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J. Exp. Med. 210(9), 1743-1759 (2013).
15. Kong XF, Bousfiha A, Rouissi A et al. A novel homozygous p.R1105X mutation of the AP4E1 gene in twins with hereditary spastic paraplegia and mycobacterial disease. PLoS ONE 8(3), e58286 (2013).
16. Casrouge A, Zhang SY, Eidenschenk C et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314(5797), 308-312 (2006).
17. Guo Y, Audry M, Ciancanelli M et al. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J. Exp. Med. 208(10), 2083-2098 (2011).
18. Herman M, Ciancanelli M, Ou YH et al. Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J. Exp. Med. 209(9), 1567-1582 (2012).
19. Perez de Diego R, Sancho-Shimizu V, Lorenzo L et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33(3), 400-411 (2010).
20. Sancho-Shimizu V, Perez de Diego R, Lorenzo L et al. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J. Clin. Invest. 121(12), 4889-4902 (2011).
21. Zhang SY, Jouanguy E, Ugolini S et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317(5844), 1522-1527 (2007).
22. Perez de Diego R, Mulvey C, Crawford M et al. The proteome of Toll-like receptor 3-stimulated human immortalized fibroblasts: Implications for susceptibility to herpes simplex virus encephalitis. J. Allergy Clin. Immunol. 131(4), 1157-1166 (2013).
23. Hill JM, Lukiw WJ, Gebhardt BM et al. Gene expression analyzed by microarrays in HSV-1 latent mouse trigeminal ganglion following heat stress. Virus Genes 23(3), 273-280 (2001).
24. Rakkola R, Matikainen S, Nyman TA. Proteome analysis of human macrophages reveals the upregulation of manganesecontaining superoxide dismutase after toll-like receptor activation. Proteomics 7(3), 378-384 (2007).
25. Saha RN, Pahan K. Differential regulation of Mn-superoxide dismutase in neurons and astroglia by HIV-1 gp120: Implications for HIV-associated dementia. Free Radic. Biol. Med. 42(12), 1866-1878 (2007).
26. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26(12), 1367-1372 (2008).
27. Foss EJ, Radulovic D, Shaffer SA, Goodlett DR, Kruglyak L, Bedalov A. Genetic variation shapes protein networks mainly through non-transcriptional mechanisms. PLoS Biol. 9(9), e1001144 (2011).
28. Foss EJ, Radulovic D, Stirewalt DL et al. Proteomic classification of acute leukemias by alignment-based quantitation of LC-MS/ MS data sets. J. Proteome Res. 11(10), 5005-5010 (2012).
29. Whitacre JM, Bender A. Networked buffering: a basic mechanism for distributed robustness in complex adaptive systems. Theor. Biol. Med. Model 7, 20 (2010).
30. Mulvey CM, Tudzarova S, Crawford M, Williams GH, Stoeber K, Godovac-Zimmermann J. Subcellular proteomics reveals a role for nucleo-cytoplasmic trafficking at the DNA replication origin activation checkpoint. J. Proteome Res. 12(3), 1436-1453 (2013).
31. Henke RM, Dastidar RG, Shah A et al. Hypoxia elicits broad and systematic changes in protein subcellular localization. Am. J. Physiol. Cell Physiol. 301(4), C913-928 (2011).
32. Itan Y, Zhang SY, Vogt G et al. The human gene connectome as a map of short cuts for morbid allele discovery. Proc. Natl Acad. Sci. USA 110(14), 5558-5563 (2013).
33. Butcher NJ, Kiehl TR, Hazrati LN et al. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications. JAMA Neurol. 70(11), 1359-1366 (2013).
34. Flinn LJ, Keatinge M, Bretaud S et al. TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency. Ann. Neurol. doi:10.1002/ana.23999. (2013) (Epub ahead of print).
35. Manzanillo PS, Ayres JS, Watson RO et al. The ubiquitin ligase parkin mediates resistance to intracellular pathogens. Nature 501, 512-516 (2013).
36. Puschmann A. Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Parkinsonism Relat. Disord. 19(4), 407-415 (2013).
37. Tsika E, Moore DJ. Contribution of GTPase activity to LRRK2-associated Parkinson disease. Small GTPases 4(3) (2013).
38. Scholz SW, Mhyre T, Ressom H, Shah S, Federoff HJ. Genomics and bioinformatics of Parkinson's disease. Cold Spring Harb. Perspect. Med. 2(7), a009449 (2012).
39. Ideker T, Krogan NJ. Differential network biology. Mol. Syst. Biol. 8, 565 (2012).